Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

DHODH inhibition enhances the efficacy of immune checkpoint blockade by increasing cancer cell antigen presentation
Nicholas J. Mullen, Surendra K. Shukla, Ravi Thakur, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 9

Showing 9 citing articles:

Targeting both the enzymatic and non-enzymatic functions of DHODH as a therapeutic vulnerability in c-Myc-driven cancer
Qiang Zhang, Kaisa Cui, Yue Kong, et al.
Cell Reports (2025) Vol. 44, Iss. 3, pp. 115327-115327
Open Access
Epithelial-mesenchymal Transition Promotes Metabolic Reprogramming to Suppress Ferroptosis
Wenzheng Guo, Zhibing Duan, Jingjing Wu, et al.
Seminars in Cancer Biology (2025)
Closed Access
Translational Pharmacokinetic-Pharmacodynamic Modeling of a Novel Oral Dihydroorotate Dehydrogenase (DHODH) Inhibitor, HOSU-53 (JBZ-001)
Joo‐Young Na, M. T. Vu Hai, Kyeongmin Kim, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 412-412
Open Access
Cutting edge: ferroptosis in metabolic dysfunction-associated steatotic liver disease (MASLD) pathogenesis and therapy
Amr Ali Mohamed Abdelgawwad El-Sehrawy, Teeba Ammar Rashid, Muhammad Ikram Ullah, et al.
Functional & Integrative Genomics (2025) Vol. 25, Iss. 1
Closed Access
Targeting vulnerability in tumor therapy: Dihydroorotate dehydrogenase
Fu Lin, Jiaxin Li, Lei Zhou, et al.
Life Sciences (2025), pp. 123612-123612
Closed Access
The perspective of targeting cancer cell metabolism: combination therapy approaches
Arezu Karimpur-zahmatkesh, Mohammad Khalaj‐Kondori
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Gemcitabine Modulates HLA-I Regulation to Improve Tumor Antigen Presentation by Pancreatic Cancer Cells
Alaina C. Larson, Shelby M. Knoche, Gabrielle L. Brumfield, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3211-3211
Open Access | Times Cited: 3
Targeting metabolic pathways to counter cancer immunotherapy resistance
Yuki Agarwala, Timothy Brauns, Ann E. Sluder, et al.
Trends in Immunology (2024) Vol. 45, Iss. 7, pp. 486-494
Closed Access | Times Cited: 3
Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future
J. J. Li, Xiaodong Wang, Honghua Zhang, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 164-213
Closed Access | Times Cited: 2
Metabolic instruction of the graft-versus-leukemia immunity
Ann‐Cathrin Burk, Petya Apostolova
Frontiers in Immunology (2024) Vol. 15
Open Access
Feasibility and Safety of Targeting Mitochondria Function and Metabolism in Acute Myeloid Leukemia
Patryk Firmanty, Monika Chomczyk, Shubhankar Dash, et al.
Current Pharmacology Reports (2024)
Open Access
Page 1

Scroll to top